Agilent Corp (A): Growth-Adjusted Market Cap to Net Income

Symbol and logo of brand Agilent Technologies (A)

The scaling of AI platforms and the robotization of analytics are defining the industry's growth trajectory. The PEG ratio trend demonstrates the fundamental stability of Agilent Technologies (A), with the parameter stabilizing at 2.69. Business resilience is supported by recurring service payments, while long-term success is driven by the synergy between top-tier engineers and an innovative environment for scientific research.

PEG Multiple: Agilent (A) for 07/04/2022 - 11/10/2026
Core merchandise of agilent.com

Agilent Technologies' leading position in analytical instrumentation and high share of recurring service revenues make this business a benchmark for cash flow stability. The current growth stock attractiveness indicator at 2.69 compares the market P/E multiple with earnings expansion rates, where a value below one signals that the asset is undervalued relative to its fundamental growth potential.

Competitors of Agilent Technologies

Growth-Adjusted Market Cap to Net Income Quest Diagnostics Inc.|Price/Earnings to Growth Ratio Illumina Corp ILMN|Growth-Adjusted Market Cap to Net Income Exact Sciences Inc. (EXAS)|Revvity, Inc. - PEG Multiple|BIO - PEG Multiple|NNNN: PEG Multiple|Price to Net Income Growth Ratio Sotera Health Corp SHC|QDEL (QuidelOrtho Corp) - PEG Multiple|OPKO Health Corp. (OPK) - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Ratio CareDx (CDNA)|Price/Earnings to Growth Ratio MRVI (maravai.com)|PEG Multiple FLGT (Fulgent Genetics)|Standard BioTools Inc (LAB) - Price to Earnings Adjusted for Growth Rate|CTKB - Price/Earnings to Growth Ratio|OSUR (OraSure Corp) - Growth-Adjusted P/E Ratio|XGN (exagen.com) - Price/Earnings to Growth Multiple|MDXH: Company Value to Earnings Growth Ratio|Price/Earnings to Growth Multiple LUCD|PRE: Growth-Adjusted Payback Ratio|Price/Earnings to Growth Multiple IMDX (Insight Molecular Diagnostics)|Company Value to Earnings Growth Ratio TRIB|PEG Multiple PRPH (ProPhase Labs, Inc.)|ainos.com (AIMD) - Price to Earnings Adjusted for Growth Rate|Co-Diagnostics - PEG Multiple|Heart Test Laboratories, Inc. (HSCS) - Price/Earnings to Growth Multiple|BMRA: PEG Multiple|Cardio Diagnostics Holdings - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Onconetix, Inc.|Growth-Adjusted P/E Ratio VRAX (viraxbiolabs.com)|Price/Earnings to Growth Ratio Bluejay Diagnostics, Inc. (BJDX)|AWH - Price to Earnings Adjusted for Growth Rate|Price/Earnings to Growth Ratio Accelerate Diagnostics, Inc AXDX|Centogene NV - Price/Earnings to Growth Ratio|ENZ - Price/Earnings to Growth Ratio|Price to Earnings Adjusted for Growth Rate Fresh2 Group Limited|GENE: PEG Multiple|Price to Net Income Growth Ratio 23andMe Holding Co ME|PMD (Psychemedics Corp) - PEG Multiple